tiprankstipranks
Trending News
More News >
Mediprss Pu (IL:MPRS)
:MPRS
Israel Market
Advertisement

Mediprss Pu (MPRS) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Mediprss Pu’s (MPRS) Moving Averages Convergence Divergence (MACD) indicator is 0.43, suggesting Mediprss Pu is a Buy.
Mediprss Pu’s (MPRS) 20-Day exponential moving average is 51.82, while Mediprss Pu’s (MPRS) share price is 51.9, making it a Buy.
Mediprss Pu’s (MPRS) 50-Day exponential moving average is 51.88, while Mediprss Pu’s (MPRS) share price is 51.9, making it a Buy.

Mediprss Pu (MPRS) Pivot Points

Sep 11, 2025, 01:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
34.60
17.30
34.60
17.30
34.60
17.30
34.60
Fibonacci
17.30
17.30
17.30
17.30
17.30
17.30
17.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Mediprss Pu (MPRS) Moving Averages

Sep 11, 2025, 01:08 PM
Period
Simple
Exponential
MA5
51.96Sell
51.97Sell
MA10
52.15Sell
52.06Sell
MA20
51.85Buy
51.82Buy
MA50
48.72Buy
51.88Buy
MA100
54.39Sell
54.85Sell
MA200
63.72Sell
61.62Sell
Mediprss Pu’s (MPRS) 10-Day exponential moving average is 52.06, while Mediprss Pu’s (MPRS) share price is 51.9, making it a Sell.
Mediprss Pu’s (MPRS) 100-Day exponential moving average is 54.85, while Mediprss Pu’s (MPRS) share price is 51.9, making it a Sell.
Mediprss Pu’s (MPRS) stock price is 51.9 and Mediprss Pu’s (MPRS) 50-day simple moving average is 48.72, creating a Buy signal.
Mediprss Pu’s (MPRS) stock price is 51.9 and Mediprss Pu’s (MPRS) 100-day simple moving average is 54.39, creating a Sell signal.
Mediprss Pu’s (MPRS) stock price is 51.9 and Mediprss Pu’s (MPRS) 200-day simple moving average is 63.72, creating a Sell signal.

Mediprss Pu (MPRS) Technical Indicators

Sep 11, 2025, 01:08 PM
Name
Value
Implied Action
RSI (14)
52.24
Neutral
STOCH (9,6)
97.92
Sell
STOCHRSI (14)
97.92
Sell
MACD (12,26)
0.43
Buy
ADX (14)
7.82
Buy
Williams %R
-2.08
Sell
CCI (14)
-52.04
Neutral
ATR (14)
36.30
-
Ultimate Oscillator
99.69
Buy
ROC
-1.70
Sell
Mediprss Pu’s (MPRS) Relative Strength Index (RSI) is 52.24, creating a Neutral signal.
Mediprss Pu’s (MPRS) Trend Strength Indicator (ADX) is 7.82, creating a Buy signal.
Mediprss Pu’s (MPRS) Commodity Channel Index (CCI) is -52.04, creating a Neutral signal.
Mediprss Pu’s (MPRS) Price Rate of Change (ROC) is -1.70, creating a Sell signal.

FAQ

Is MPRS a Buy, Hold, or Sell?
Based on MPRS’s technical indicators, MPRS is a Sell.
    What is MPRS’s RSI (14)?
    MPRS’s RSI (14) is 52.24, which suggests MPRS is a Neutral.
      What is MPRS’s MACD?
      MPRS’s MACD is 0.43, which suggests MPRS is a Buy.
        What is MPRS’s 5-day moving average?
        MPRS’s 5-day moving average is 51.96, which suggests MPRS is a Sell.
          What is MPRS’s 20-day moving average?
          MPRS 20-day moving average is 51.85, which suggests MPRS is a Buy.
            What is MPRS’s 50-day moving average?
            MPRS’s 50-day moving average is 48.72, which suggests MPRS is a Buy.
              What is MPRS’s 200-day moving average?
              MPRS’s 200-day moving average is 63.72, which suggests MPRS is a Sell.
                What is MPRS’s Williams % R (14)?
                MPRS’s Williams % R (14) is -2.08, which suggests MPRS is a Sell.
                  What is MPRS’s CCI (14)?
                  MPRS’s CCI (14) is -52.04, which suggests MPRS is a Neutral.
                    What is the share price of Mediprss Pu?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis